stockportfolio.pro
Stocks / BEAM vs GPCR
BEAM vs GPCR
Beam Therapeutics Inc. and Structure Therapeutics Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Beam Therapeutics Inc. (BEAM) | Structure Therapeutics Inc. (GPCR) | |
|---|---|---|
| Market cap | $3.0B | $3.0B |
| Revenue (latest FY) | $139.74M | $0 |
| Net income (latest FY) | $-79.99M | $-141.20M |
| Revenue growth (5y CAGR) | 466.3% | — |
| Net margin | -57.2% | — |
| Return on equity | -6.5% | -9.3% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BEAM — free Open GPCR — freeFrequently asked questions
Which is bigger, BEAM or GPCR?
Beam Therapeutics Inc. is larger by market capitalization — $3.0B versus $3.0B.
Which grows faster, BEAM or GPCR?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.